Systemic Therapy With Oncolytic Myxoma Virus Cures Established Residual Multiple Myeloma in Mice

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1038/mto.2016.32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Oncolytic Virotherapy for Multiple Myeloma Using a Tumour-Specific Double-Deleted Vaccinia Virus

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Dynamics of Multiple Myeloma Tumor Therapy With a Recombinant Measles Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

Oncolytic Myxoma Virus Synergizes With Standard of Care for Treatment of Glioblastoma Multiforme

Oncolytic Virotherapy
2018English

Broad Antigenic Coverage Induced by Vaccination With Virus-Based cDNA Libraries Cures Established Tumors

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Myxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma Cells

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Oncolytic Virotherapy as an Immunotherapeutic Strategy for Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2017English

Human Myeloma Cell Line (KHM-4) Established From a Patient With Multiple Myeloma Associated With Hyperammonemia.

Internal Medicine
Internal MedicineMedicine
1992English

BiTE Therapy Active in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy